Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease

被引：18
作者：
Black, Ana Paula [1 ]
Cardozo, Ludmila F. M. F. [2 ]
Mafra, Denise [1 ,2 ]
机构：
[1] Univ Fed Fluminense, Grad Program Med Sci, Niteroi, RJ, Brazil
[2] Univ Fed Fluminense, Grad Program Cardiovasc Sci, Niteroi, RJ, Brazil
来源：
THERAPEUTIC APHERESIS AND DIALYSIS | 2015年 / 19卷 / 05期
关键词：
Bone mineral disease; Chronic kidney disease; Uremic toxins; P-CRESYL SULFATE; INDOXYL SULFATE; OXIDATIVE STRESS; SKELETAL RESISTANCE; CLASSIFICATION; ASSOCIATION; PROGRESSION; MORTALITY;
D O I：
10.1111/1744-9987.12307
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Patients with chronic kidney disease (CKD) frequently have mineral and bone disorders (CKD-MBD) that are caused by several mechanisms. Recent research has suggested that uremic toxins from the gut such as p-cresyl sulfate (PCS) and indoxyl sulfate (IS) could also be involved in the development of bone disease in patients with CKD. IS and PCS are produced by microbiota in the gut, carried into the plasma bound to serum albumin, and are normally excreted into the urine. However, in patients with CKD, there is an accumulation of high levels of these uremic toxins. The exact mechanisms of action of uremic toxins in bone disease remain unclear. The purpose of this brief review is to discuss the link between uremic toxins (IS and PCS) and bone mineral disease in chronic kidney disease.
引用
收藏
页码：436 / 440
页数：5
相关论文
共 38 条
[31]   Indoxyl sulfate-lowering capacity of oral sorbents affects the prognosis of kidney function and oxidative stress in chronic kidney disease [J].
Taki, Kentaro ;
Niwa, Toshimitsu .
JOURNAL OF RENAL NUTRITION, 2007, 17 (01) :48-52
[32]   p-Cresyl sulfate induces osteoblast dysfunction through activating JNK and p38 MAPK pathways [J].
Tanaka, Hisae ;
Iwasaki, Yoshiko ;
Yamato, Hideyuki ;
Mori, Yoshitaka ;
Komaba, Hirotaka ;
Watanabe, Hiroshi ;
Maruyama, Toru ;
Fukagawa, Masafumi .
BONE, 2013, 56 (02) :347-354
[33]   Role of Uremic Toxins and Oxidative Stress in the Development of Chronic Kidney Disease-Mineral and Bone Disorder [J].
Tanaka, Hisae ;
Komaba, Hirotaka ;
Koizumi, Masahiro ;
Kakuta, Takatoshi ;
Fukagawa, Masafumi .
JOURNAL OF RENAL NUTRITION, 2012, 22 (01) :98-101
[34]   Review on uremic toxins:: Classification, concentration, and interindividual variability [J].
Vanholder, R ;
De Smet, R ;
Glorieux, G ;
Argilés, A ;
Baurmeister, U ;
Brunet, P ;
Clark, W ;
Cohen, G ;
De Deyn, PP ;
Deppisch, R ;
Descamps-Latscha, B ;
Henle, T ;
Jörres, A ;
Lemke, HD ;
Massy, ZA ;
Passlick-Deetjen, J ;
Rodriguez, M ;
Stegmayr, B ;
Stenvinkel, P ;
Tetta, C ;
Wanner, C ;
Zidek, W .
KIDNEY INTERNATIONAL, 2003, 63 (05) :1934-1943
[35]   Chronic kidney disease alters intestinal microbial flora [J].
Vaziri, Nosratola D. ;
Wong, Jakk ;
Pahl, Madeleine ;
Piceno, Yvette M. ;
Yuan, Jun ;
DeSantis, Todd Z. ;
Ni, Zhenmin ;
Nguyen, Tien-Hung ;
Andersen, Gary L. .
KIDNEY INTERNATIONAL, 2013, 83 (02) :308-315
[36]   p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase [J].
Watanabe, Hiroshi ;
Miyamoto, Yohei ;
Honda, Daisuke ;
Tanaka, Hisae ;
Wu, Qiong ;
Endo, Masayuki ;
Noguchi, Tsuyoshi ;
Kadowaki, Daisuke ;
Ishima, Yu ;
Kotani, Shunsuke ;
Nakajima, Makoto ;
Kataoka, Keiichiro ;
Kim-Mitsuyama, Shokei ;
Tanaka, Motoko ;
Fukagawa, Masafumi ;
Otagiri, Masaki ;
Maruyama, Toru .
KIDNEY INTERNATIONAL, 2013, 83 (04) :582-592
[37]   p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease [J].
Wu, I-Wen ;
Hsu, Kuang-Hung ;
Lee, Chin-Chan ;
Sun, Chiao-Yin ;
Hsu, Heng-Jung ;
Tsai, Chi-Jen ;
Tzen, Chin-Yuan ;
Wang, Yen-Chih ;
Lin, Ching-Yuang ;
Wu, Mai-Szu .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (03) :938-947
[38]   Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats [J].
Yisireyili, Maimaiti ;
Shimizu, Hidehisa ;
Saito, Shinichi ;
Enomoto, Atsushi ;
Nishijima, Fuyuhiko ;
Niwa, Toshimitsu .
LIFE SCIENCES, 2013, 92 (24-26) :1180-1185
1234